Litcius/Paper detail

Comparison of persistence rates between allopurinol and febuxostat as first-line urate-lowering therapy in patients with gout: an 8-year retrospective cohort study

Aran Kim, Yunkyung Kim, Geun-Tae Kim, Eunyoung Ahn, Min Wook So, Seung‐Geun Lee

2020Clinical Rheumatology28 citationsDOI

Topics & Concepts

FebuxostatAllopurinolMedicineGoutInternal medicineRetrospective cohort studyHyperuricemiaProportional hazards modelCohortRheumatologyPersistence (discontinuity)Xanthine oxidase inhibitorSurgeryUric acidXanthine oxidaseEngineeringBiochemistryEnzymeGeotechnical engineeringChemistryGout, Hyperuricemia, Uric AcidThyroid Disorders and TreatmentsRheumatoid Arthritis Research and Therapies
Comparison of persistence rates between allopurinol and febuxostat as first-line urate-lowering therapy in patients with gout: an 8-year retrospective cohort study | Litcius